PATENT CLAIM ANALYSIS

Application Number: 16001318
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "001000"]

Abstract:
The present disclosure in various embodiments teaches methods of treating patients in need of treatment with a Factor Xa inhibitor, and who are also concomitantly administered verapamil.

Claim (Index 11):
The method of  claim 1 , wherein the patient is has a CL Cr  of 30-59 mL/min.

Metadata:
- Claim Count in Document: 87.0
- Percentile: 94.0
- Lexical Diversity: 1.07407
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13128459', '13184704', '13454286', '13454255', '12688038']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7458757622944149
- 35 USC 102 Novelty (BERT): 0.5286169107189163
- Combined Prediction Score: 0.7241498771368651
- Mean Citation Score: 244.7395
- Max Citation Score: 258.22217
- Similarity Product: 135.94768943114997

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test